Varley, James A.
Strippel, Christine
Handel, Adam
Irani, Sarosh R. http://orcid.org/0000-0002-7667-9748
Funding for this research was provided by:
Medical Research Centre
Wellcome Trust
British Medical Association
Epilepsy Research UK
NIHR Oxford Biomedical Research Centre
Article History
Received: 3 March 2023
Revised: 23 March 2023
Accepted: 23 March 2023
First Online: 28 April 2023
Declarations
:
: SRI has received honoraria and/or research support from UCB, Immunovant, MedImmun, Roche, Janssen, Cerebral therapeutics, ADC therapeutics, Brain, CSL Behring, and ONO Pharma, and receives licensed royalties on patent application WO/2010/046716 entitled 'Neurological Autoimmune Disorders’, and has filed two other patents, currently without licencees (“Diagnostic method and therapy”: WO2019211633 and US-2021-0071249-A1; PCT application WO202189788A1) and “Biomarkers” (PCT/GB2022/050614 and WO202189788A1).